Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet

Abstract Background This study aimed to compare the characteristics of the gut microbiota and their metabolite profiles between polycystic ovary syndrome (PCOS) and orlistat-treated PCOS rats (ORL-PCOS), which could help to better understand the underlying mechanism of the effect of orlistat on PCOS...

Full description

Bibliographic Details
Main Authors: Jianmei Yang, Enli Wang, Mingmin Jiang, Yujun Tan, Fangfang Yao, Chenghong Sun, Lihong Pan, Ling Gao, Jingchun Yao
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Journal of Ovarian Research
Subjects:
Online Access:https://doi.org/10.1186/s13048-023-01193-3
_version_ 1797806554953547776
author Jianmei Yang
Enli Wang
Mingmin Jiang
Yujun Tan
Fangfang Yao
Chenghong Sun
Lihong Pan
Ling Gao
Jingchun Yao
author_facet Jianmei Yang
Enli Wang
Mingmin Jiang
Yujun Tan
Fangfang Yao
Chenghong Sun
Lihong Pan
Ling Gao
Jingchun Yao
author_sort Jianmei Yang
collection DOAJ
description Abstract Background This study aimed to compare the characteristics of the gut microbiota and their metabolite profiles between polycystic ovary syndrome (PCOS) and orlistat-treated PCOS rats (ORL-PCOS), which could help to better understand the underlying mechanism of the effect of orlistat on PCOS. Methods PCOS rat models were established using letrozole combined with a high-fat diet. Ten rats were randomly selected as a PCOS control group (PCOS). The other three groups (n = 10/group) were additionally supplemented with different doses of orlistat (low, medium, high). Then, fecal samples of the PCOS and ORL-PCOS groups were analysed by 16S rRNA gene sequencing and untargeted metabolomics. Blood samples were collected to detect serum sex hormones and lipids. Results The results showed that orlistat attenuated the body weight gain, decreased the levels of T, LH, the LH/FSH ratio, TC, TG and LDL-C; increased the level of E2; and improved estrous cycle disorder in PCOS rats. The bacterial richness and diversity of the gut microbiota in the ORL-PCOS group were higher than those in the PCOS group. The ratio of Firmicutes to Bacteroidetes was decreased with orlistat treatment. Moreover, orlistat treatment led to a significant decrease in the relative abundance of Ruminococcaceae and Lactobacillaceae, and increases in the abundances of Muribaculaceae and Bacteroidaceae. Metabolic analysis identified 216 differential fecal metabolites in total and 6 enriched KEGG pathways between the two groups, including steroid hormone biosynthesis, neuroactive ligand-receptor interaction and vitamin digestion and absorption. Steroid hormone biosynthesis was the pathway with the most significant enrichment. The correlations between the gut microbiota and differential metabolites were calculated, which may provide a basis for understanding the composition and function of microbial communities. Conclusions Our data suggested that orlistat exerts a PCOS treatment effect, which may be mediated by modifying the structure and composition of the gut microbiota, as well as the metabolite profiles of PCOS rats.
first_indexed 2024-03-13T06:09:02Z
format Article
id doaj.art-165ebaa59435459b8d1147b1ce6f8df8
institution Directory Open Access Journal
issn 1757-2215
language English
last_indexed 2024-03-13T06:09:02Z
publishDate 2023-06-01
publisher BMC
record_format Article
series Journal of Ovarian Research
spelling doaj.art-165ebaa59435459b8d1147b1ce6f8df82023-06-11T11:22:26ZengBMCJournal of Ovarian Research1757-22152023-06-0116111410.1186/s13048-023-01193-3Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat dietJianmei Yang0Enli Wang1Mingmin Jiang2Yujun Tan3Fangfang Yao4Chenghong Sun5Lihong Pan6Ling Gao7Jingchun Yao8Department of Pediatric Endocrinology, Shandong Provincial Hospital, Shandong UniversityState Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co. Ltd.State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co. Ltd.State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co. Ltd.State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co. Ltd.State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co. Ltd.State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co. Ltd.Scientific Center, Shandong Provincial Hospital, Shandong UniversityState Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co. Ltd.Abstract Background This study aimed to compare the characteristics of the gut microbiota and their metabolite profiles between polycystic ovary syndrome (PCOS) and orlistat-treated PCOS rats (ORL-PCOS), which could help to better understand the underlying mechanism of the effect of orlistat on PCOS. Methods PCOS rat models were established using letrozole combined with a high-fat diet. Ten rats were randomly selected as a PCOS control group (PCOS). The other three groups (n = 10/group) were additionally supplemented with different doses of orlistat (low, medium, high). Then, fecal samples of the PCOS and ORL-PCOS groups were analysed by 16S rRNA gene sequencing and untargeted metabolomics. Blood samples were collected to detect serum sex hormones and lipids. Results The results showed that orlistat attenuated the body weight gain, decreased the levels of T, LH, the LH/FSH ratio, TC, TG and LDL-C; increased the level of E2; and improved estrous cycle disorder in PCOS rats. The bacterial richness and diversity of the gut microbiota in the ORL-PCOS group were higher than those in the PCOS group. The ratio of Firmicutes to Bacteroidetes was decreased with orlistat treatment. Moreover, orlistat treatment led to a significant decrease in the relative abundance of Ruminococcaceae and Lactobacillaceae, and increases in the abundances of Muribaculaceae and Bacteroidaceae. Metabolic analysis identified 216 differential fecal metabolites in total and 6 enriched KEGG pathways between the two groups, including steroid hormone biosynthesis, neuroactive ligand-receptor interaction and vitamin digestion and absorption. Steroid hormone biosynthesis was the pathway with the most significant enrichment. The correlations between the gut microbiota and differential metabolites were calculated, which may provide a basis for understanding the composition and function of microbial communities. Conclusions Our data suggested that orlistat exerts a PCOS treatment effect, which may be mediated by modifying the structure and composition of the gut microbiota, as well as the metabolite profiles of PCOS rats.https://doi.org/10.1186/s13048-023-01193-3OrlistatObesityPolycystic ovary syndromeGut microbiotaMetabolomics
spellingShingle Jianmei Yang
Enli Wang
Mingmin Jiang
Yujun Tan
Fangfang Yao
Chenghong Sun
Lihong Pan
Ling Gao
Jingchun Yao
Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet
Journal of Ovarian Research
Orlistat
Obesity
Polycystic ovary syndrome
Gut microbiota
Metabolomics
title Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet
title_full Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet
title_fullStr Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet
title_full_unstemmed Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet
title_short Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet
title_sort integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high fat diet
topic Orlistat
Obesity
Polycystic ovary syndrome
Gut microbiota
Metabolomics
url https://doi.org/10.1186/s13048-023-01193-3
work_keys_str_mv AT jianmeiyang integratedfecalmicrobiotaandmetabolomicsanalysisoftheorlistatinterventioneffectonpolycysticovarysyndromeratsinducedbyletrozolecombinedwithahighfatdiet
AT enliwang integratedfecalmicrobiotaandmetabolomicsanalysisoftheorlistatinterventioneffectonpolycysticovarysyndromeratsinducedbyletrozolecombinedwithahighfatdiet
AT mingminjiang integratedfecalmicrobiotaandmetabolomicsanalysisoftheorlistatinterventioneffectonpolycysticovarysyndromeratsinducedbyletrozolecombinedwithahighfatdiet
AT yujuntan integratedfecalmicrobiotaandmetabolomicsanalysisoftheorlistatinterventioneffectonpolycysticovarysyndromeratsinducedbyletrozolecombinedwithahighfatdiet
AT fangfangyao integratedfecalmicrobiotaandmetabolomicsanalysisoftheorlistatinterventioneffectonpolycysticovarysyndromeratsinducedbyletrozolecombinedwithahighfatdiet
AT chenghongsun integratedfecalmicrobiotaandmetabolomicsanalysisoftheorlistatinterventioneffectonpolycysticovarysyndromeratsinducedbyletrozolecombinedwithahighfatdiet
AT lihongpan integratedfecalmicrobiotaandmetabolomicsanalysisoftheorlistatinterventioneffectonpolycysticovarysyndromeratsinducedbyletrozolecombinedwithahighfatdiet
AT linggao integratedfecalmicrobiotaandmetabolomicsanalysisoftheorlistatinterventioneffectonpolycysticovarysyndromeratsinducedbyletrozolecombinedwithahighfatdiet
AT jingchunyao integratedfecalmicrobiotaandmetabolomicsanalysisoftheorlistatinterventioneffectonpolycysticovarysyndromeratsinducedbyletrozolecombinedwithahighfatdiet